NGN Biomed 1A
NGN Capital · adviser of record: NGN Capital LLC · 2011 vintage
NGN Biomed 1A is a 2011 venture fund managed by NGN Capital. It reported $0k in gross assets at year-end 2021, against a peak of $49.7mm in 2011.
- Latest value held
- $0k year-end 2021
- Peak
- $49.7mm year-end 2011
- Fund size
- Not on file
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2021 | $0k | – | -100% |
| 2020 | $556k | – | -85% |
| 2019 | $3.6mm | – | -35% |
| 2018 | $5.5mm | – | -13% |
| 2017 | $6.3mm | – | +77% |
| 2016 | $3.6mm | – | -60% |
| 2015 | $8.9mm | – | -68% |
| 2014 | $28.2mm | – | -43% |
| 2013 | $49.7mm | – | +0% over 2 yrs |
| 2011 | $49.7mm | – | – |
Other funds from NGN Capital
- NGN Optiscan Fund II, LP 2019
- NGN Optiscan Fund I, LP 2018
- NGN Biomed Opportunity Annex Fund LP 2013
- NGN Biomed 2A 2011
- NGN Biomed 1B 2011
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-5936958052. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.